- Home
- VNRX vs NCSM Comparison
VNRX vs NCSM Comparison
Compare VNRX & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- NCSM
- Stock Information
- Founded
- VNRX N/A
- NCSM 2006
- Country
- VNRX United States
- NCSM United States
- Employees
- VNRX N/A
- NCSM N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NCSM Oilfield Services/Equipment
- Sector
- VNRX Health Care
- NCSM Energy
- Exchange
- VNRX Nasdaq
- NCSM Nasdaq
- Market Cap
- VNRX 69.7M
- NCSM 76.3M
- IPO Year
- VNRX N/A
- NCSM 2017
- Fundamental
- Price
- VNRX $0.45
- NCSM $36.90
- Analyst Decision
- VNRX Strong Buy
- NCSM
- Analyst Count
- VNRX 4
- NCSM 0
- Target Price
- VNRX $3.50
- NCSM N/A
- AVG Volume (30 Days)
- VNRX 712.7K
- NCSM 15.7K
- Earning Date
- VNRX 11-13-2025
- NCSM 10-31-2025
- Dividend Yield
- VNRX N/A
- NCSM N/A
- EPS Growth
- VNRX N/A
- NCSM N/A
- EPS
- VNRX N/A
- NCSM 4.71
- Revenue
- VNRX $1,319,252.00
- NCSM $175,468,000.00
- Revenue This Year
- VNRX $324.32
- NCSM $11.91
- Revenue Next Year
- VNRX $247.82
- NCSM $7.63
- P/E Ratio
- VNRX N/A
- NCSM $7.73
- Revenue Growth
- VNRX 35.10
- NCSM 19.31
- 52 Week Low
- VNRX $0.40
- NCSM $17.30
- 52 Week High
- VNRX $0.94
- NCSM $53.69
- Technical
- Relative Strength Index (RSI)
- VNRX 30.37
- NCSM 35.33
- Support Level
- VNRX $0.43
- NCSM $40.53
- Resistance Level
- VNRX $0.52
- NCSM $44.71
- Average True Range (ATR)
- VNRX 0.05
- NCSM 2.59
- MACD
- VNRX -0.02
- NCSM -1.46
- Stochastic Oscillator
- VNRX 7.58
- NCSM 5.55
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.